Skip to content

Clinical trials

Dyslipidemias trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Country / region: Bulgaria Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20101
20131
20161
20171
20211
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
89bio, Inc.1
Amgen1
AstraZeneca1
Kowa Research Institute, Inc.1
Regeneron Pharmaceuticals1
Takeda1
Tanabe Pharma Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias10
Hypercholesterolemia5
Hyperlipidemias4
Cardiovascular Diseases2
Lipid Metabolism Disorders2
Angina Pectoris1
Atherosclerosis1
Coronary Artery Disease1
Coronary Stenosis1
Diabetes Mellitus1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.